Format

Send to

Choose Destination
Clin Chem. 2019 May 14. pii: clinchem.2018.298620. doi: 10.1373/clinchem.2018.298620. [Epub ahead of print]

Biobanking for Metabolomics and Lipidomics in Precision Medicine.

Author information

1
Head of the BIH Metabolomics Platform, Max Delbrück Center for Molecular Medicine in the Helmholtz association, Berlin, Germany; jennifer.kirwan@mdc-berlin.de.
2
Head of the BIH Metabolomics Platform, Berlin Institute of Health, Berlin, Germany.
3
Professor, Psychiatry and Behavioral Sciences, Duke Institute for Brain Sciences, Duke University, Durham, NC.
4
Associate Professor, School of Medicine, University of Wollongong, Wollongong, Australia.
5
Head of the Lipidomics Laboratory, Illawarra Health and Medical Research Institute, Keiraville, Australia.
6
Research Group Head, Molecular Epidemiology Research Group, Max Delbrück Center for Molecular Medicine, Berlin, Germany.
7
Professor, Molecular Epidemiology, Charité Universitätsmedizin, Berlin, Germany.
8
Director, MDC/BIH Biobank, Berlin Institute of Health, Berlin, Germany.
9
Chair, Advanced Pattern Analysis & Countermeasures Group, Boulder, CO.
10
CEO & CSO, Sovaris Aerospace, Boulder, CO.
11
Director and Chair, National Metabolomics Core Facility, Technology Center, Institute for Molecular Medicine FIMM, HiLIFE, University of Helsinki, Finland.

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center